Plasma lipid alterations in African-American women with breast cancer

被引:21
作者
Agurs-Collins, T
Kim, KS
Dunston, GM
Adams-Campbell, LL
机构
[1] Howard Univ, Ctr Canc, Div Epidemiol & Biostat, Washington, DC 20060 USA
[2] Howard Univ, Coll Med, Dept Microbiol & Immunol, Washington, DC USA
关键词
triglycerides; lipids; lipoproteins; breast cancer;
D O I
10.1007/s004320050153
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The purpose of this study was to examine the relationship between plasma lipid and lipoprotein levels, stage of disease and breast cancer risk in African-American women. The study population comprised 163 African-American women: patients (n = 58) and controls (n = 105), with mean ages of 57.2 years and 47.7 years respectively. Approximately 71% and 56% of the women with breast cancer and the control population, respectively, were postmenopausal. Those with cancer had significantly higher education levels, P less than or equal to 0.01, and higher triglyceride levels compared to the controls, P less than or equal to 0.001, but lower body mass index (BMI) levels, P less than or equal to 0.01. There were no statistically significant differences observed in total cholesterol, high-density-lipoprotein-containing cholesterol and low-density-lipoprotein-containing cholesterol between the patients and controls. After adjustments for age, education, BMI, and menopausal status, triglycerides remained significantly and positively associated with breast cancer risk. The significant correlation between the high levels of triglycerides and breast cancer risk (odds ratio = 5.12) may be attributed to differences in lipid metabolism between the women with breast cancer and controls, or to the consequences of breast cancer.
引用
收藏
页码:186 / 190
页数:5
相关论文
共 26 条
[1]   PLASMA-LIPIDS AND PROLACTIN IN PATIENTS WITH BREAST-CANCER [J].
BANI, IA ;
WILLIAMS, CM ;
BOULTER, PS ;
DICKERSON, JWT .
BRITISH JOURNAL OF CANCER, 1986, 54 (03) :439-446
[2]  
BARCLAY M, 1967, CANCER RES, V27, P1158
[3]  
BORELLI R, 1993, ADV NUTR CANC, P149
[4]   INSULIN RESISTANCE AND BREAST-CANCER RISK [J].
BRUNING, PF ;
BONFRER, JMG ;
VANNOORD, PAH ;
HART, AAM ;
DEJONGBAKKER, M ;
NOOIJEN, WJ .
INTERNATIONAL JOURNAL OF CANCER, 1992, 52 (04) :511-516
[5]   PECULIARITIES OF HYPERLIPEMIA IN TUMOR PATIENTS [J].
DILMAN, VM ;
BERSTEIN, LM ;
OSTROUMOVA, MN ;
TSYRLINA, YV ;
GOLUBEV, AG .
BRITISH JOURNAL OF CANCER, 1981, 43 (05) :637-643
[6]   RACIAL-DIFFERENCES IN SURVIVAL FROM BREAST-CANCER - RESULTS OF THE NATIONAL-CANCER-INSTITUTE BLACK/WHITE CANCER SURVIVAL STUDY [J].
ELEY, JW ;
HILL, HA ;
CHEN, VW ;
AUSTIN, DF ;
WESLEY, MN ;
MUSS, HB ;
GREENBERG, RS ;
COATES, RJ ;
CORREA, P ;
REDMOND, CK ;
HUNTER, CP ;
HERMAN, AA ;
KURMAN, R ;
BLACKLOW, R ;
SHAPIRO, S ;
EDWARDS, BK .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1994, 272 (12) :947-954
[7]   CIRCULATING LIPIDS AND LIPOPROTEINS IN WOMEN WITH METASTATIC BREAST CARCINOMA [J].
FELDMAN, EB ;
CARTER, AC .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1971, 33 (01) :8-+
[8]  
FREDERICK GL, 1956, CANCER RES, V16, P548
[9]   RISK OF BREAST-CANCER IN RELATION TO BLOOD-LIPIDS - A PROSPECTIVE-STUDY OF 31,209 NORWEGIAN WOMEN [J].
GAARD, M ;
TRETLI, S ;
URDAL, P .
CANCER CAUSES & CONTROL, 1994, 5 (06) :501-509
[10]  
GERBER M, 1989, CANCER, V64, P2347, DOI 10.1002/1097-0142(19891201)64:11&lt